338 related articles for article (PubMed ID: 33965437)
1. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses.
Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K
Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.
Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA
PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3.
Bakovic A; Bhalla N; Alem F; Campbell C; Zhou W; Narayanan A
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452398
[TBL] [Abstract][Full Text] [Related]
4. Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus.
Nguyen TH; Haese NN; Madadi N; Sarkar S; Bonin K; Streblow CE; Taft-Benz S; Tower NA; Rasmussen L; Bostwick R; Augelli-Szafran CE; Suto MJ; Morrison TE; DeFilippis V; Heise MT; Streblow DN; Pathak AK
ACS Infect Dis; 2019 Dec; 5(12):2014-2028. PubMed ID: 31257853
[TBL] [Abstract][Full Text] [Related]
5. Venezuelan Equine Encephalitis Virus nsP3 Phosphorylation Can Be Mediated by IKKβ Kinase Activity and Abrogation of Phosphorylation Inhibits Negative-Strand Synthesis.
Bakovic A; Bhalla N; Kortchak S; Sun C; Zhou W; Ahmed A; Risner K; Klimstra WB; Narayanan A
Viruses; 2020 Sep; 12(9):. PubMed ID: 32933112
[TBL] [Abstract][Full Text] [Related]
6. Benzamidine ML336 inhibits plus and minus strand RNA synthesis of Venezuelan equine encephalitis virus without affecting host RNA production.
Skidmore AM; Adcock RS; Jonsson CB; Golden JE; Chung DH
Antiviral Res; 2020 Feb; 174():104674. PubMed ID: 31816348
[TBL] [Abstract][Full Text] [Related]
7. Emergence and Magnitude of ML336 Resistance in Venezuelan Equine Encephalitis Virus Depend on the Microenvironment.
Lee J; Parvathareddy J; Yang D; Bansal S; O'Connell K; Golden JE; Jonsson CB
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878897
[TBL] [Abstract][Full Text] [Related]
8. Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections.
Ahmed A; Siman-Tov G; Keck F; Kortchak S; Bakovic A; Risner K; Lu TK; Bhalla N; de la Fuente-Nunez C; Narayanan A
Antiviral Res; 2019 Apr; 164():61-69. PubMed ID: 30738837
[TBL] [Abstract][Full Text] [Related]
9. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
[TBL] [Abstract][Full Text] [Related]
10. Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses.
Lundberg L; Brahms A; Hooper I; Carey B; Lin SC; Dahal B; Narayanan A; Kehn-Hall K
Antiviral Res; 2018 Sep; 157():57-67. PubMed ID: 29981794
[TBL] [Abstract][Full Text] [Related]
11. β-d-
Urakova N; Kuznetsova V; Crossman DK; Sokratian A; Guthrie DB; Kolykhalov AA; Lockwood MA; Natchus MG; Crowley MR; Painter GR; Frolova EI; Frolov I
J Virol; 2018 Feb; 92(3):. PubMed ID: 29167335
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection.
Risner K; Ahmed A; Bakovic A; Kortchak S; Bhalla N; Narayanan A
Viruses; 2019 Dec; 11(12):. PubMed ID: 31842327
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses.
Jonsson CB; Cao X; Lee J; Gabbard JD; Chu YK; Fitzpatrick EA; Julander J; Chung DH; Stabenow J; Golden JE
Antiviral Res; 2019 Jul; 167():25-34. PubMed ID: 30970271
[TBL] [Abstract][Full Text] [Related]
14. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
[TBL] [Abstract][Full Text] [Related]
15. Protein Phosphatase 1α Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.
Carey BD; Ammosova T; Pinkham C; Lin X; Zhou W; Liotta LA; Nekhai S; Kehn-Hall K
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769351
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
17. Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay.
Ferreira-Ramos AS; Li C; Eydoux C; Contreras JM; Morice C; Quérat G; Gigante A; Pérez Pérez MJ; Jung ML; Canard B; Guillemot JC; Decroly E; Coutard B
Antiviral Res; 2019 Mar; 163():59-69. PubMed ID: 30639438
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel antivirals inhibiting recognition of Venezuelan equine encephalitis virus capsid protein by the Importin α/β1 heterodimer through high-throughput screening.
Thomas DR; Lundberg L; Pinkham C; Shechter S; DeBono A; Baell J; Wagstaff KM; Hick CA; Kehn-Hall K; Jans DA
Antiviral Res; 2018 Mar; 151():8-19. PubMed ID: 29337164
[TBL] [Abstract][Full Text] [Related]
19. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses.
Boghdeh NA; McGraw B; Barrera MD; Anderson C; Baha H; Risner KH; Ogungbe IV; Alem F; Narayanan A
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
